GenoSmart
Diagnostic Solutions for Accurate Diagnosis of Pathogens
Company Overview
Snapshot
Founded in March 2007 by Ofer Zohar, GenoSmart operated with 1–10 employees. GenoSmart ceased operations in November 2024.
Business overview
GenoSmart developed diagnostic solutions for the rapid and accurate diagnosis of pathogens such as antibiotic-resistant bacteria, pandemic viruses, and bio-terror agents. Its core technology included a proprietary bio-electronic molecular diagnostic device, the Miniature Enthalpy-Meter, and an adaptable automatic nucleic acid purification device, Automated Nucleic Acid Extraction (ANAE). The company served markets within the Health Tech & Life Sciences sector, specifically focusing on medical devices and diagnostics for healthcare providers and biotechnology applications.
Log in to access full profile ›Company Intelligence Q&A
- What is GenoSmart's primary focus?
- GenoSmart focuses on developing diagnostic solutions for the rapid and accurate detection of pathogens, including antibiotic-resistant bacteria, pandemic viruses, and bio-terror agents.
- What is the Miniature Enthalpy-Meter?
- The Miniature Enthalpy-Meter is GenoSmart's proprietary versatile bio-electronic molecular diagnostic device designed for rapid and accurate pathogen diagnosis by detecting minute changes in the kinetic energy of molecules.
- What is the Automated Nucleic Acid Extraction (ANAE) device?
- ANAE is GenoSmart's proprietary adaptable automatic nucleic acid purification device that rapidly and efficiently purifies DNA or RNA from any source in one automatic step, compatible with various separation methods.
- When was GenoSmart founded?
- GenoSmart was founded in March 2007.
- What was the operational status of GenoSmart?
- GenoSmart ceased to operate in November 2024.